1.
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
Hiramatsu, R, Ubara, Y, Sawa, N, Hoshino, J, Hasegawa, E, Kawada, M, Imafuku, A, Sumida, K, Mise, K, Hayami, N, et al
American journal of kidney diseases : the official journal of the National Kidney Foundation. 2015;(1):175-7